Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Mimedx (MDXG) Inventory (2016 - 2025)

Historic Inventory for Mimedx (MDXG) over the last 16 years, with Q3 2025 value amounting to $26.5 million.

  • Mimedx's Inventory rose 929.11% to $26.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.5 million, marking a year-over-year increase of 929.11%. This contributed to the annual value of $23.8 million for FY2024, which is 1325.34% up from last year.
  • Mimedx's Inventory amounted to $26.5 million in Q3 2025, which was up 929.11% from $24.9 million recorded in Q2 2025.
  • Mimedx's Inventory's 5-year high stood at $26.5 million during Q3 2025, with a 5-year trough of $10.1 million in Q2 2021.
  • In the last 5 years, Mimedx's Inventory had a median value of $16.8 million in 2023 and averaged $18.0 million.
  • Its Inventory has fluctuated over the past 5 years, first crashed by 405.11% in 2021, then surged by 6684.18% in 2024.
  • Over the past 5 years, Mimedx's Inventory (Quarter) stood at $11.4 million in 2021, then rose by 15.75% to $13.2 million in 2022, then surged by 59.46% to $21.0 million in 2023, then increased by 13.25% to $23.8 million in 2024, then increased by 11.32% to $26.5 million in 2025.
  • Its Inventory stands at $26.5 million for Q3 2025, versus $24.9 million for Q2 2025 and $24.1 million for Q1 2025.